Flagship Pioneering

Investment thesis

Operates a proprietary venture-creation ('origination') model: rather than backing existing startups, it conceives, iterates on and launches new companies in-house around breakthrough biology, new modalities and platforms. Runs an internal pipeline of ProtoCos each year and funds them through growth.

Notable portfolio

Sector focus